Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapybrachytherapyimage guided radiation therapy (IGRT)focused ultrasoundstereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

Videos | AAPM | August 01, 2018

American Association of Physicists in Medicine (AAPM) President Bruce Thomadsen, M.D., professor of medical physics...

IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan
News | Proton Therapy | July 30, 2018

July 30, 2018 – IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the...

MIM Software Inc. Collaborating With Radialogica to Provide Monte Carlo Dose Calculation
News | Radiation Therapy | July 30, 2018

July 30, 2018 — MIM Software Inc. announced its intention to collaborate with Radialogica to provide an integrated,...

Varian Showcases Advanced Cancer Care Solutions at AAPM 2018
News | Radiation Therapy | July 27, 2018

July 27, 2018 — Varian announced it will be showcasing its advanced cancer care solutions, including a new version...

IBA Dosimetry Launches SmartScan Automated and Guided Beam Commissioning Solution
Technology | Quality Assurance (QA) | July 27, 2018

July 27, 2018 – IBA (Ion Beam Applications S.A.) announced the market launch of its new SmartScan solution at the...

New RayCare and RayStation Releases on Show at AAPM
Technology | Radiation Therapy | July 26, 2018

July 26, 2018 — RaySearch will exhibit its latest advances in...

Magseed magnetic marker
Technology | Tumor Tracking Systems | July 20, 2018

Endomag, the surgical guidance company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA)...

SpaceOAR Hydrogel Now Available in Japan
News | Patient Positioning Radiation Therapy | July 16, 2018

July 16, 2018 — Augmenix K.K. announced that SpaceOAR hydrogel, a soft, implanted absorbable gel...

RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018

July 13, 2018 — RaySearch has released RayCare 2A, the latest version of its flagship...

Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018

July 11, 2018 — Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG)...

MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018

July 5, 2018 — MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the...

Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018

Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of...

Proton Treatment System
Feature | Proton Therapy | July 03, 2018 | By Jeff Zagoudis

The Alliance for Proton Therapy Access (APTA) released a national report in late May revealing the heavy emotional...

 JoVE_Radiation_Planning_Assistant_schematic
Feature | Treatment Planning | July 03, 2018 | By Jeff Zagoudis

A new software developed and recently tested at the MD Anderson Cancer Center demonstrated the ability to largely...

Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018

July 2, 2018 — Researchers at The University of Kansas Cancer Center have launched a...

SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018

June 29, 2018 — In the battle against metastatic castrate-resistant...

Technology | Focused Ultrasound Therapy | June 19, 2018

June 19, 2018 — EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its...

Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018

June 18, 2018 — Elekta announced that its Elekta Unity...

Overlay Init